➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Fipamezole

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Fipamezole?

Fipamezole is an investigational drug.

There have been 4 clinical trials for Fipamezole. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2008.

The most common disease conditions in clinical trials are Parkinson Disease, Shy-Drager Syndrome, and Multiple System Atrophy. The leading clinical trial sponsors are Valeant Pharmaceuticals International, Inc., Juvantia Pharma Ltd, and Santhera Pharmaceuticals.

Recent Clinical Trials for Fipamezole
A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's DiseaseValeant Pharmaceuticals International, Inc.Phase 1/Phase 2
A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving LevodopaValeant Pharmaceuticals International, Inc.Phase 1
Fipamezole in Neurogenic Orthostatic HypotensionSanthera PharmaceuticalsPhase 2

See all Fipamezole clinical trials

Clinical Trial Summary for Fipamezole

Top disease conditions for Fipamezole
Top clinical trial sponsors for Fipamezole

See all Fipamezole clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.